Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U ...

Shares of the American pharmaceutical company Moderna (MRNA) climbed over 8% in pre-market trading following strategic ...

A German court on Wednesday ruled that Pfizer and its partner BioNTech violated a COVID-19 vaccine patent held by Moderna. In ...

Moderna Inc. expects to launch a personalized cancer vaccine that it’s developing with Merck & Co. by 2027, one of its top ...

The S&P 500 advanced 1.1% on Wednesday, March 5, as the White House announced it would delay tariffs affecting U.S.

U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...

Arbutus Biopharma and Genevant Sciences are broadening the scope of their patent infringement claims against Moderna with ...

Moderna’s respiratory syncytial virus (RSV) vaccine mRESVIA has been approved by the Medicines and Healthcare products ...

Moderna, Inc. ( NASDAQ: MRNA) TD Cowen 45th Annual Health Care Conference March 5, 2025 9:10 AM ET All right, well, good morning, everyone. Tyler Van Buren here, Senior Biotech Analyst at TD Cowen.

For now, Moderna may be a good stock to put on a watch list, but it's likely too risky and volatile for the vast majority of ...

Madison Mills examines the trending headlines Wall Street investors need to know on today's Market Minute. Moderna (MRNA) shares pop after a German court ruled that Pfizer (PFE) and BioNTech (BNTX) ...

The court said Pfizer and BioNTech would have to provide information on earnings derived from the use of the patent and that ...